ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $830,930 | -27.5% | 23,308 | -6.2% | 0.00% | -40.0% |
| Q2 2023 | $1,145,869 | +4674.5% | 24,840 | +6048.5% | 0.01% | – |
| Q2 2022 | $24,000 | +26.3% | 404 | +56.0% | 0.00% | – |
| Q1 2022 | $19,000 | -9.5% | 259 | +4.4% | 0.00% | – |
| Q4 2021 | $21,000 | +75.0% | 248 | +85.1% | 0.00% | – |
| Q3 2021 | $12,000 | -7.7% | 134 | -4.3% | 0.00% | – |
| Q2 2021 | $13,000 | -83.1% | 140 | -79.2% | 0.00% | -100.0% |
| Q1 2021 | $77,000 | +2.7% | 674 | +24.6% | 0.00% | 0.0% |
| Q4 2020 | $75,000 | – | 541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $4,658,000 | 2.63% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,364,434 | $84,745,000 | 1.21% |
| CAPITAL INTERNATIONAL LTD /CA/ | 259,700 | $16,130,000 | 1.07% |
| Aureus Asset Management, LLC | 65,670 | $4,079,000 | 0.69% |
| Capital International Sarl | 124,320 | $7,722,000 | 0.67% |
| CAPITAL GUARDIAN TRUST CO | 512,430 | $31,827,000 | 0.58% |
| ROCKEFELLER FINANCIAL SERVICES INC | 408,379 | $25,365,000 | 0.50% |
| Rock Springs Capital Management LP | 160,500 | $9,969,000 | 0.50% |
| Hood River Capital Management LLC | 112,296 | $6,975,000 | 0.48% |
| Capital International, Inc./CA/ | 52,700 | $3,273,000 | 0.47% |